Trial of Genentech drug shows promise in treating asthma, cutting side effects.

dc.date.accessioned2000-08-06en_US
dc.date.accessioned2009-05-29T05:42:23Z
dc.date.available2000-08-06en_US
dc.date.available2009-05-29T05:42:23Z
dc.date.issued2000-08-06en_US
dc.identifier.citationEditor. Trial of Genentech drug shows promise in treating asthma, cutting side effects. Indian Journal of Medical Sciences. 2000 Aug; 54(8): 362-3en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/67961
dc.language.isoengen_US
dc.source.urihttps://www.indianjmedsci.orgen_US
dc.subject.meshAntibodies, Monoclonal --administration & dosageen_US
dc.subject.meshAsthma --drug therapyen_US
dc.subject.meshClinical Trials as Topicen_US
dc.subject.meshDrug Industryen_US
dc.subject.meshDrugs, Investigational --administration & dosageen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunoglobulin E --drug effectsen_US
dc.titleTrial of Genentech drug shows promise in treating asthma, cutting side effects.en_US
dc.typeNewsen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: